Navigation Links
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
Date:7/31/2008

FOSRENOL 42.4 73% -4% 8.2%

XAGRID 20.6 20% n/a n/a

Human Genetic Therapies

ELAPRASE 80.8 89% n/a n/a

REPLAGAL 44.7 40% n/a n/a

(1) Product specific prescription data is provided by IMS Health

("IMS"), a leading global provider of business intelligence for the

pharmaceutical and healthcare industries. All other US market share

data stated in the text below is also provided by IMS.

(2) Compared to Q2 2007.

Specialty Pharmaceuticals

US ADHD market share Shire's average quarterly market share of the US ADHD market rose to 32.3% in the three months to June 30, 2008 (2007: 28.6%), driven by the introduction of VYVANSE in July 2007. The overall US ADHD market grew by 7% in the same period. Shire has the leading portfolio of products in the US ADHD market.

ADDERALL XR - ADHD

As a result of the launch of VYVANSE in July 2007, ADDERALL XR's average quarterly market share of the US ADHD market for Q2 2008 fell to 23.1% (2007: 26.3%), a decrease of 12% compared to Q2 07. US prescriptions for ADDERALL XR for the period to June 30, 2008 decreased by 6% compared to the same period in 2007 due to the 12% decrease in average market share offset by 7% growth in the US ADHD market.

Sales of ADDERALL XR for the three months to June 30, 2008 were $296.4 million, an increase of 16% compared to the same period in 2007 (2007: $255.1 million). Product sales grew despite the decline in US prescriptions primarily due to price increases in October 2007 and April 2008.

Litigation proceedings concerning Shire's ADDERALL XR patents are ongoing. Further information on this litigation can be found in our filings with the US Securities and Exchange Commission ("SEC"), including our Annual Report on Form 10-K for th
'/>"/>

SOURCE Shire Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. Shire Engages Palio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...RA, Ontario, Nov. 6 Heli...HXBPF) today announced that John Docherty, preside...rriman Curhan Ford,s 6th annual Investor Summit on... in New York City. Mr. Docherty will provide an o...nt programs L-DOS47 and Topical Interferon Alpha-2...
(Date:11/6/2009)...ARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Bi... the "Company") today announced updated results fr...patients with sarcomas metastatic to the lung in a... Tissue Oncology Society Meeting held in Miami Bea...presentation, entitled "A Phase II Study of Intrav...
(Date:11/5/2009)...INGTON, Colo., Nov. 5 The endanger...in the western U.S. This rare carnivore feeds on ...ble to plague and often entire population die-offs...vice (FWS) has implemented a ferret breeding progr... into their formerly native habitat. Unfortunatel...
(Date:11/5/2009)...A, Neb., Nov. 5 Transgen...ced financial results for the quarter ended Septem...presented in the tables that follow. ,, Third ...s of $366,000 or $0.01 per share for the third qua... or $0.01 per share for the third quarter of 2008....
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
... Studies show that up to 30% ...gh levels of caffeine. Now you can know for sure w...strip from Silver Lake Research, the leader in at-...). , Monrovia, CA (PRWEB)...ee you had after dinner was really decaf? Now you...
...Televised Surgery at a Prestigious Russian Eye Sur...opean Conference in Moscow, MOSCOW, Nov. 12 A Ve...dating Crystalens surgery in Russia when he implan...ataract patient. Dr. Jack Singer,of the Singer Eye... at the,Ninth International Conference on Modern T...
...N, Nov. 12 WHO and CDC have stated that the,predi...man influenza,vaccines is "suboptimal" -- often co...iors. Perhaps in part because we are not yet accur...ns, approximately 36,000 people,die each year of f... hurricanes, early warning of the location and,int...
Other Biology Technology:Is Your Decaf Really Decaf? Use New "D+CAF (tm) Caffeine Test Strips" to Know for Sure 2Vermont Surgeon Implants First Accommodating Crystalens in Russia 2A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 2A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 3
(Date:11/8/2009)...H INTELLECTUAL DISABILITIES: AN OPPORTUNITY FOR HE...olving adults with intellectual disabilities found...nowledge after taking a semi-weekly class for four...cepted term for mental retardation, have slightly ...reventable chronic diseases compared to the genera...
(Date:11/6/2009)... Society of Interventional Radiology,s "Image-guid..., which will provide the latest updates on percuta... kidney tumor ablation and lung tumor ablation. SI...ists and allied health professionals dedicated to ...s in image-guided therapy. , The Webinar, which ...
(Date:11/6/2009)...h of the publication of On the Origin of Species, ...S) is publishing open access two peer-reviewed art...ts into evolution. , The two articles are by Kevi..., and James T. Costa of Western Carolina Universit...in," appeared in the October issue of the AIBS jou...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Zeus 3A Dedicated to Advancing Biomaterial Technology with Enhanced Capabilities 14294 1Zeus 3A Dedicated to Advancing Biomaterial Technology with Enhanced Capabilities 14294 2PAREXEL International to Present at William Blair Emerging Growth Stock Conference 5096 1PAREXEL International to Present at William Blair Emerging Growth Stock Conference 5096 2Harris Corporation Demonstrates Secure Exchange of Public Health Information in Cloud Computing Environment 58517 1Harris Corporation Demonstrates Secure Exchange of Public Health Information in Cloud Computing Environment 58517 2Harris Corporation Demonstrates Secure Exchange of Public Health Information in Cloud Computing Environment 58517 3
...ity of California, Berkeley, virologist and an ass...crobial Biology, has won a W. M. Keck Foundation g...s in the area of biomedical research. , The grant...ill go to UC Berkeley to support Glaunsinger,s wor...er workings of human cells. , The foundation gran...
... cause of death but now a study of brain tissue co...derlying cause of major depression and suicide. T...l O. Poulter of Robarts Research Institute at The ...n of the Neuroscience Research Institute at Carlet...that modify DNA directly are more highly expressed...
...y of California, San Francisco, have identified a ...t has been killing parrots and exotic birds for mo...sors Joseph DeRisi, PhD, and Don Ganem, MD, also h...d to Proventricular Dilation Disease, or PDD, whic...he spread of the virus. , Results of the study wi...
Other Biology News:UC Berkeley virologist named Keck Distinguished Young Scholar 2Study identifies changes to DNA in major depression and suicide 2UCSF researchers identify virus behind mysterious parrot disease 2
Sheep NP-SGG (Sheep Gamma Globulin), Unconjugated from Biosearch Technologies
...boxes are ideal for use in refrigerators, freezers...rious storage racks. Four vibrant colors allow for... the bottom allow liquid nitrogen drainage or prom...1.6 mm cell) grid which holds 100 tubes. Box dim...
Rabbit Anti-PSMC1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Bovine NIP-BSA (Bovine Serum Albumin), BSA (Bovine Serum Albumin) conjugated/tagged from Biosearch Technologies
Biology Products: